GeoVax Labs Inc. (NASDAQ: GOVX) is a biotechnology company that specializes in developing and commercializing treatments for various cancers and viral conditions. Many describe GeoVax
Yesterday, the vaccines developer biotech, GeoVax Labs Inc. (GOVX) announced a patent for its malaria vaccine candidate. Coming on the heels of a cancer vaccine
On 10th March 2021, GeoVax Labs Inc. (GOVX) got invited to present at the Maxim Group’s Inaugural Emerging Growth Virtual Conference that is to be held on
Sundial Growers Inc. (SNDL) stock soared 1.72% to $0.5088 in the pre-market trading after declaring $50 million prepayment on senior secured non-revolving term credit facility.
Xenetic Biosciences Inc. (XBIO) stock plunged -15.46% to $2.68 in the pre-market trading following the company’s announcement of $6.0 million registered direct offering priced at-the-market
It is evident with so many people focused on COVID-19 that biotech stocks with coronavirus vaccines and treatments have gained a lot of attention. The
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.